Raman Spectroscopy Market

The report "Raman Spectroscopy Market by Type (Benchtop, Portable), Instrument (Microscopy, FT, Handheld & Portable), Sampling Technique (Surface-enhanced Raman Scattering, Tip-enhanced Raman Scattering), Application and Region - Global Forecast to 2028" The Raman spectroscopy market is expected to reach USD 1.1 billion by 2028 from USD 0.8  billion in 2023, at a CAGR of 7.0% during the 2023–2028 period.

The major factors driving the market growth of the Raman spectroscopy market include increased focus on drug development in healthcare sector, rise in adoption of Raman spectroscopy in clinical applications, growing awareness regarding food safety, etc.

Browse 138 market data Tables and 67 Figures spread through 257 Pages and in-depth TOC on "Raman Spectroscopy Market by Type (Benchtop, Portable), Instrument (Microscopy, FT, Handheld & Portable), Sampling Technique (Surface-enhanced Raman Scattering, Tip-enhanced Raman Scattering), Application and Region- Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/raman-spectroscopy-market-23875879.html

Handheld & Portable Raman sub-segment in instrument segment is expected to grow at the highest CAGR of the Raman spectroscopy market during the forecast period.

Handheld Raman is an industry-changing technology that has drastically impacted the pharmaceutical and chemical industries’ quality control process for incoming raw material testing. It provides the safety and security market an easy-to-use tool for field identification of unknown, suspicious, potentially hazardous or illicit substances. Raman spectroscopy has always provided nondestructive testing with the advantage over other methods of high specificity without requiring sample preparation or direct contact with the sample. Raman has the unique capability of being able to test a sample directly through transparent packing material like glass or plastic, therefore decreasing exposure to samples and maintaining sample integrity. With the added benefit of portability, handheld Raman spectrometers considerably increase efficiency by bringing the instrument to the sample, allowing for streamlined work processes.

Pharmaceuticals application is expected to account for the highest market share of the Raman spectroscopy market during the forecast period.

Pharmaceuticals are substances used in disease diagnosis, treatment, and prevention and for correction, restoration, and modification of organic functions. Pharmaceuticals are generally categorized as chemical groups based on pharmacological effects and their therapeutic use. Alkaloids were the first naturally derived pharmaceuticals, which include quinine, nicotine, cocaine, atropine, and morphine. Other important pharmaceuticals derived from natural substances include antibiotics, vaccines, human blood plasma fractions, and steroid hormones. Many pharmaceutical drugs, such as insulin, are derived from glandular extracts of animals. Vitamins, which were earlier derived from natural substances, are processed in labs now. Many pharmaceuticals are now prepared in laboratories varying their degree of fineness. These include solutions such as spirits, elixirs, and tinctures; ointments such as creams, pastes, and jellies; and solid pharmaceuticals such as pills, tablets, lozenges, and suppositories.

The pharmaceutical industry uses Raman spectroscopy extensively for various analytical purposes, including drug development and quality control. In Raman spectroscopy, the scattered light that results from illuminating an object with a monochromatic laser is measured. The scattered light reveals the vibrational energy levels of the sample's molecule bonds, which can be used to determine the sample’s chemical structure and bond nature. Raman spectroscopy can analyze samples in their natural form without the need for sample preparation or labeling, which is one of its main benefits. Raman spectroscopy can therefore be used to identify drug compounds, evaluate pharmaceutical formulations, and track the stability of medicines over time quickly and easily. Additionally, Raman spectroscopy can be used to spot fake medications, which is a significant issue in the pharmaceutical sector.

Asia Pacific is expected to register the highest market share during the forecast period.

The major drivers for the growth of the market in Asia Pacific include the rising investment in research towards cloud-based spectroscopy and the regulatory push to introduce process analytical technologies (PAT). PAT-enabled Raman spectrometers are now available in the market. In addition, the ongoing urbanization, increasing investments by global healthcare solution providers to improve healthcare devices, and the rising focus on drug development in this region are the major factors contributing to the high demand for Raman spectroscopy solutions. China is likely to be the fastest-growing market for Raman spectroscopy in Asia Pacific during the forecast period. The growth of the market in China can be attributed to the rising demand for Raman spectroscopy in pharmaceutical, life science, and materials science applications. The rising R&D initiatives in biomedicals in China is among the leading factors fueling the growth of the Raman spectroscopy market.

The report profiles key players such as Thermo Fisher Scientific Inc. (US), Mettler Toledo (Switzerland), Agilent Technologies Inc. (US), Bruker (US), Renishaw Plc (UK), Rigaku Corporation (Japan), Oxford Instruments (UK), Endress+Hauser Group Services AG (Switzerland), HORIBA Ltd. (Japan), PerkinElmer Inc. (US), Hamamatsu Photonics K.K (Japan), Metrohm AG (Switzerland), Anton Paar GmbH (Austria), JASCO (Japan), Tornado Spectral Systems (Canada), Enhanced Spectrometry, Inc. (US), Zolix (China), Smiths Detection (UK), Ocean Insight (US), Ostec (US), TSI (US), Laser Detect System (Israel), Photon Systems, Inc. (US), B&W Tek (US), and Real Time Analyzers (US).

Don’t miss out on business opportunities in Raman Spectroscopy Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]